Promega Hosts Fight Colorectal Cancer (Fight CRC) Research Advocacy Training and Support (RATS) Program
Madison, WI USA. (October 11, 2019)
During the two-day interactive training event on the Promega Madison campus, participants will have the unique opportunity to engage in lab activities with Promega scientists while learning about topics such as:
- molecular oncology workflow
- genomic analysis for cancer
- bioluminescence and drug discovery
- immunotherapy and hereditary cancer risk
- microsatellite instability (MSI)
“We’re excited about this opportunity to work alongside advocates for colorectal cancer research in our Promega labs to offer them an up-close, hands-on perspective of the research process and learn from each of their particular experiences as well,” says Heather Tomlinson, Director of Clinical Diagnostics at Promega “We are especially eager to share our insight of the role inherited genetic conditions such as Lynch syndrome plays in increasing the likelihood of developing colorectal and other types of cancer, and how simple screening tests performed on cancerous tumor tissue can determine if Lynch syndrome is likely.”
This is the first Fight CRC RATS research academy Promega has hosted and is a continuation of the company’s commitment, announced in March for Colorectal Cancer Awareness month and National Lynch Syndrome Awareness Day (March 22), to advance colorectal cancer education.
Learn more about Promega support of colorectal cancer research.
About Promega Corporation
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 4,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, drug discovery and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.